040-000-310 Abiraterone Acetate CAS 154229-18-2

SKU: 040-000-310 Category:
Get A Quote

  I would like to join the mailing list to receive updates from Stanford Chemicals.
*: e-mail address with your company's domain name is preferred. Otherwise, we may not be able to process your inquiry.

Synonyms Abiraterone
Keywords metastatic castration-resistant prostate cancer
Related products Red clover extract,  Viagra (Sildenafil Citrate) Powder


Abiraterone Acetate Specifications

Product Name Abiraterone Acetate
CAS Registry Number 154229-18-2
Molecular Formula C26H33NO2
Molecular Weight 391.55 g/mol
Purity >99.0 %
Appearance White powder
Package 1kg-25kg
Shelf life 2 years
Functions Treatment of mCSPC

Abiraterone Acetate Description:

Abiraterone Acetate is a CYP17 inhibitor, suitable for use in combination with prednisone for the treatment of patients with metastatic castration-refractory prostate cancer who have previously received docetaxel-containing chemotherapy.

ZYTIGA (abiraterone acetate) is a prescription medicine that is used along with prednisone. ZYTIGA is used to treat men with prostate cancer that has spread to other parts of the body.

abiraterone acetate

Abiraterone Acetate Applications:

Abiraterone Acetate is used in combination with prednisone, a corticosteroid, as a treatment for mCRPC (previously called hormone-resistant or hormone-refractory prostate cancer).


  1. O’Donnell, A., Judson, I., Dowsett, M., et al. Hormonal impact of the 17α-hydroxylase/C17,20-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancer. British Journal of Cancer 90(12), 2317-2325 (2004).
  2. Ryan, C.J., Smith, M.R., de Bono, J.S., et al. Abiraterone in metastatic prostate cancer without previous chemotherapy. New England Journal of Medicine 368(2), 138-148 (2013).
  3. Potter, G.A., Barrie, S.E., Jarman, M., et al. Novel steroidal inhibitors of human cytochrome P45017α (17α-hydroxylase-C17,20-lyase): Potential agents for the treatment of prostatic cancer. Journal of Medicinal Chemistry 38(13), 2463-2471 (1995).